10/15/2026
DECODE, the Digital Endpoint Collaboration for Outcomes DEvelopment, is Ametris' pre-competitive framework designed to mobilize the life sciences industry around shared clinical measurement challenges that no single organization can take on alone.
Digital measures used in clinical trials must be meaningful to patients, scientifically valid, operationally feasible, and regulatory aligned. The DECODE framework was developed to advance the development and validation of fit-for-purpose digital clinical measures for indications where traditional measurements fall short.
Through industry stakeholder consensus-building, patient engagement, clinical study and regulatory alignment, and shared evidence generation, each DECODE project aims to close these clinical measurement gaps, so patients get the treatments they need, faster.
This 60-minute session begins with an update on the regulatory landscape for Digitally Derived Measures. We’ll then introduce the DECODE framework and present key results from the first DECODE initiatives and the launch of new DECODE initiatives in respiratory, cardiometabolic, and neuroscience. We’ll wrap up the session with a multidisciplinary panel discussion of speakers from Brown University and Roche and a Q&A from the audience.
🎙️Speakers:
🔹Chat Gwaltney, PhD at Brown University
🔹Jonas Dorn, PhD at Roche
🔹Sylvain Zorman, PhD at Ametris
🔹Christine Guo, PhD at Ametris
Join us Wednesday, October 28th, 2026 at 12-1pm EST for our next Digital Health Monthly. Register for the webinar: https://hubs.la/Q04BjwPQ0
